A
Abhijit Chakraborty
Researcher at Baylor College of Medicine
Publications - 28
Citations - 401
Abhijit Chakraborty is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 9, co-authored 28 publications receiving 292 citations. Previous affiliations of Abhijit Chakraborty include The Texas Heart Institute & Bose Corporation.
Papers
More filters
Journal ArticleDOI
Cancer Care Delivery Challenges Amidst Coronavirus Disease - 19 (COVID-19) Outbreak: Specific Precautions for Cancer Patients and Cancer Care Providers to Prevent Spread.
Abhishek Shankar,Deepak Saini,Shubham Roy,Alireza Mosavi Jarrahi,Abhijit Chakraborty,Sachidanand Jee Bharti,Farzad Taghizadeh-Hesary +6 more
TL;DR: Oncologists and other health care professionals involved in cancer care have a critical opportunity to communicate to their patients to pass on right information regarding practice modifications in view of COVID-19 outbreaks.
Journal ArticleDOI
Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
TL;DR: Until effective vaccines and treatments emerge, it is important to understand the scientific rationale of pandemic-mitigation strategies such as wearing facemasks and social distancing, and implement them.
Journal ArticleDOI
Sexual Dysfunction in Females after Cancer Treatment: an Unresolved Issue
Abhishek Shankar,Neelam J. S. S. V. Prasad,Shubham Roy,Abhijit Chakraborty,Aalekhya Sharma Biswas,Jaineet Patil,Goura Kishor Rath +6 more
TL;DR: The phases of sexual response are reviewed and how each may be affected by the physical and emotional stress of cancer diagnosis and treatment and existing tools for assessment of sexual function and approaches to their treatment are discussed.
Journal ArticleDOI
The Potential Utility of Acceptance and Commitment Therapy (ACT) for Reducing Stress and Improving Wellbeing in Cancer Patients in Kolkata.
TL;DR: Acceptance and commitment therapy can be an effective intervention approach for cancer patients that increases acceptance regarding disease and simultaneously leads to improvement in the meaning of life.
Journal ArticleDOI
Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target.
Martin Hinsch,Abhijit Chakraborty,Abhijit Chakraborty,Yang Li,Yang Li,b4migpd985,b4migpd985,Chen Zhang,Chen Zhang,Herman Ouseley,Yanming Li,Yanming Li,Scott A. LeMaire,Scott A. LeMaire,Ying H. Shen,Ying H. Shen +15 more
TL;DR: In this paper, a review of different types of programmed cell death pathways and their features, induction, contributions to AAD development, and therapeutic potential is presented, highlighting the clinical significance of programmed cells death for further studies.